A focussed research programme has developed Allogran-R, a highly consistent, polycrystalline and porous ß tri-calcium phosphate bone substitute.

Biocomposites' proprietary process provides a synthetic and multiporous granular matrix with outstanding biocompatibility.

Allogran-R, ß tri-calcium phosphate is fully resorbed through dissolution and cell mediation to be replaced by new bone.

Extensive research has shown a complete non-toxic and favourable immunological reaction to the ß tri-calcium phosphate.

Studies also show its conversion in-vivo to hydroxyapatite - the mineral constituent of natural bone.

Early cases of delayed union have shown Allogran-R to fully resorb concurrently with its replacement by new bone.

KEY ADVANTAGES
• Engineered porosity for complete resorption
• Osteoconductive
• Proven biocompatibility
• No risk of disease transmission or antigenicity
• Elimination of donor site morbidity

INDICATIONS
• Delayed union or non-union
• Trauma
• Spinal Cases